Escherichia coli (E. coli) is a facultative anaerobic bacterium, easily cultured in labs, making it a key model organism in genetics, microbiology, and biotechnology. It is commonly used for large-scale production of therapeutic proteins, with 30% of approved therapeutic proteins produced using E. coli. Beckman Coulter Life Sciences demonstrates the use of the BioLector microbioreactor and the Multisizer 4e Coulter Counter to optimize E. coli culture conditions and characterize cell gro
AdaptHealth Corp. (NASDAQ:AHCO) Q1 2024 Earnings Call Transcript insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.
WOBURN, Mass., May 3, 2024 /PRNewswire/ Curiox Biosystems Co. Ltd , a leader in the innovation of life science research technologies, and Beckman Coulter Life Sciences, a global leader in.
INDIANAPOLIS – (April 30, 2024) – Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, has entered a collaborative partnership with Watchmaker Genomics, an expert in genomics tools development for high-stringency clinical and translational applications. The partnership.